MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Causey, K. M.
Right arrow Articles by Backes, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Causey, K. M.
Right arrow Articles by Backes, W. L.

Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2- dependent activities

KM Causey, CS Eyer and WL Backes

Department of Pharmacology, Louisiana State University Medical Center, New Orleans 70112.

The effect of dilauroylphosphatidylcholine (DLPC) concentration on cytochrome P-450 LM2 (LM2)-dependent reduction and monooxygenase activities was examined as a function of preincubation time. Purified NADPH-cytochrome P-450 reductase (reductase) and LM2 were reconstituted at different DLPC to LM2 ratios by preincubation of the proteins in the presence of DLPC for either 5 min or 2 hr at room temperature. After preincubation was complete, the samples were assayed for either monooxygenase activity or first-electron transfer activity. When preincubated for 5 min, overall monooxygenase activity was dependent on the [DLPC]:[LM2] ratio, beginning at a low level in the absence of phospholipid and increasing to a maximum at a 160:1 ratio. At [DLPC]:[LM2] ratios above 160:1, the rate was decreased to 80% of the maximum rate. When the samples were preincubated for 2 hr, again low monooxygenase activities were obtained in the absence of DLPC, which increased to a maximum at 160:1 [DLPC]:[LM2] ratio. Above this [DLPC]:[LM2]ratio, the rate was decreased to less than 50% of the maximum value. These changes in overall activities appear to be related to changes in the amount of functional reductase-LM2 complex formed. Similar results were found when LM2 reduction was examined. When preincubated for 5 min, LM2 reduction was shown to be diminished as the DLPC to LM2 ratio decreased below 160:1. The DLPC-dependent effect on reduction was primarily characterized by alterations in the fraction of LM2 reduced in the first phase, with the first-phase rate constant and the slow phase parameters being largely unaffected. Below a 16:1 ratio [( DLPC]:[LM2]), no phospholipid stimulation of LM2 reduction was observed. When the [DLPC]:[LM2] ratio was increased above a 160:1 ratio, only a small effect on the kinetic constants was observed, which was characterized by a 20% decrease in the fraction of LM2 reduced in the first phase. LM2 reduction was more sensitive to DLPC concentration after longer preincubations (2 hr), with a 50% decrease in the fraction of reduction in the first phase being observed at [DLPC]:[LM2] ratios above 160:1. The results are consistent with a dual role for phospholipid in the stimulation of LM2-dependent activities. First, DLPC facilitates the association of reductase and LM2 and, second, DLPC provides a matrix for the incorporation of LM2 and reductase. Facilitation of the protein association appears to be a relatively rapid process, occurring after a 5-min preincubation, whereas a 2-hr preincubation altered the protein interactions in a manner consistent with incorporation of the LM2 and reductase into the phospholipid.

Volume 38, Issue 1, pp. 134-142, 07/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. R. Reed, L. M. Brignac-Huber, and W. L. Backes
Physical Incorporation of NADPH-Cytochrome P450 Reductase and Cytochrome P450 into Phospholipid Vesicles Using Glycocholate and Bio-Beads
Drug Metab. Dispos., March 1, 2008; 36(3): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. R. Reed, R. W. Kelley, and W. L. Backes
AN EVALUATION OF METHODS FOR THE RECONSTITUTION OF CYTOCHROMES P450 AND NADPH P450 REDUCTASE INTO LIPID VESICLES
Drug Metab. Dispos., April 1, 2006; 34(4): 660 - 666.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Ozalp, E. Szczesna-Skorupa, and B. Kemper
BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS
Drug Metab. Dispos., September 1, 2005; 33(9): 1382 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Hazai and D. Kupfer
INTERACTIONS BETWEEN CYP2C9 AND CYP2C19 IN RECONSTITUTED BINARY SYSTEMS INFLUENCE THEIR CATALYTIC ACTIVITY: POSSIBLE RATIONALE FOR THE INABILITY OF CYP2C19 TO CATALYZE METHOXYCHLOR DEMETHYLATION IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., January 1, 2005; 33(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. A. Murtazina, U. Andersson, I.-S. Hahn, I. Bjorkhem, G. A. S. Ansari, and I. A. Pikuleva
Phospholipids modify substrate binding and enzyme activity of human cytochrome P450 27A1
J. Lipid Res., December 1, 2004; 45(12): 2345 - 2353.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. F. Cawley, S. Zhang, R. W. Kelley, and W. L. Backes
Evidence Supporting the Interaction of CYP2B4 and CYP1A2 in Microsomal Preparations
Drug Metab. Dispos., December 1, 2001; 29(12): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Gruenke, K. Konopka, M. Cadieu, and L. Waskell
The Stoichiometry of the Cytochrome P-450-catalyzed Metabolism of Methoxyflurane and Benzphetamine in the Presence and Absence of Cytochrome b(5)
J. Biol. Chem., October 20, 1995; 270(42): 24707 - 24718.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics